Resuscitative Endovascular Balloon Occlusion Of The Aorta Market (2024 - 2030) Size, Share & Trends Analysis Report By End-use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                     1.1. Market Segmentation & Scope
                     1.2. Segment Definitions
                         1.2.1. End Use
                         1.2.2. Regional scope
                         1.2.3. Estimates and forecasts timeline
                     1.3. Research Methodology
                     1.4. Information Procurement
                         1.4.1. Purchased database
                         1.4.2. GVR’s internal database
                         1.4.3. Secondary sources
                         1.4.4. Primary research
                     1.5. Information or Data Analysis
                         1.5.1. Data analysis models
                     1.6. Market Formulation & Validation
                     1.7. Model Details
                         1.7.1. Commodity flow analysis (Model 1)
                         1.7.2. Approach 1: Commodity flow approach
                         1.7.3. Volume price analysis (Model 2)
                         1.7.4. Approach 2: Volume price analysis
                     1.8. List of Secondary Sources
                     1.9. List of Primary Sources
                     1.10. Objectives
Chapter 2. Executive Summary
                     2.1. Market Outlook
                     2.2. Segment Outlook
                         2.2.1. End Use outlook
                         2.2.2. Regional outlook
                     2.3. Competitive Insights
Chapter 3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Variables, Trends & Scope
                     3.1. Market Lineage Outlook
                         3.1.1. Parent market outlook
                         3.1.2. Related/ancillary market outlook
                     3.2. Market Dynamics
                         3.2.1. Market driver analysis
                              3.2.1.1. Increasing incidence of trauma cases
                              3.2.1.2. Technological advancements
                              3.2.1.3. Growing awareness and training programs
                              3.2.1.4. Military applications
                         3.2.2. Market restraint analysis
                              3.2.2.1. Cost considerations
                              3.2.2.2. Regulatory challenges
                     3.3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Analysis Tools
                         3.3.1. Industry Analysis - Porter’s
                              3.3.1.1. Supplier power
                              3.3.1.2. Buyer power
                              3.3.1.3. Substitution threat
                              3.3.1.4. Threat of new entrant
                              3.3.1.5. Competitive rivalry
                         3.3.2. PESTEL Analysis
                              3.3.2.1. Political landscape
                              3.3.2.2. Technological landscape
                              3.3.2.3. Economic landscape
Chapter 4. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Estimates & Trend Analysis
                     4.1. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Dashboard
                     4.2. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Movement Analysis
                     4.3. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Estimates and Forecasts, by End Use, Revenue (USD Million)
                     4.4. Cardiac Arrest
                         4.4.1. Cardiac arrest market estimates and forecasts 2018 to 2030 (USD Million)
                     4.5. Aortic Occlusion
                         4.5.1. Aortic occlusion market estimates and forecasts 2018 to 2030 (USD Million)
                     4.6. Tactical Combat Casualty Care
                         4.6.1. Tactical combat casualty care market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: Regional Estimates & Trend Analysis by Application, Type, and End Use
                     5.1. Regional Dashboard
                     5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                     5.3. North America
                         5.3.1. U.S.
                              5.3.1.1. Key country dynamics
                              5.3.1.2. Regulatory framework/ reimbursement structure
                              5.3.1.3. Competitive scenario
                              5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                         5.3.2. Canada
                              5.3.2.1. Key country dynamics
                              5.3.2.2. Regulatory framework/ reimbursement structure
                              5.3.2.3. Competitive scenario
                              5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                     5.4. Europe
                         5.4.1. UK
                              5.4.1.1. Key country dynamics
                              5.4.1.2. Regulatory framework/ reimbursement structure
                              5.4.1.3. Competitive scenario
                              5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                         5.4.2. Germany
                              5.4.2.1. Key country dynamics
                              5.4.2.2. Regulatory framework/ reimbursement structure
                              5.4.2.3. Competitive scenario
                              5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                         5.4.3. France
                              5.4.3.1. Key country dynamics
                              5.4.3.2. Regulatory framework/ reimbursement structure
                              5.4.3.3. Competitive scenario
                              5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                         5.4.4. Italy
                              5.4.4.1. Key country dynamics
                              5.4.4.2. Regulatory framework/ reimbursement structure
                              5.4.4.3. Competitive scenario
                              5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                         5.4.5. Spain
                              5.4.5.1. Key country dynamics
                              5.4.5.2. Regulatory framework/ reimbursement structure
                              5.4.5.3. Competitive scenario
                              5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                     5.5. Asia Pacific
                         5.5.1. Japan
                              5.5.1.1. Key country dynamics
                              5.5.1.2. Regulatory framework/ reimbursement structure
                              5.5.1.3. Competitive scenario
                              5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                         5.5.2. China
                              5.5.2.1. Key country dynamics
                              5.5.2.2. Regulatory framework/ reimbursement structure
                              5.5.2.3. Competitive scenario
                              5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                     6.1. Company/Competition Categorization
                     6.2. Vendor Landscape
                         6.2.1. List of key distributors and channel partners
                         6.2.2. Key customers
                         6.2.3. Key company market share analysis, 2023
                         6.2.4. Prytime Medical Devices, Inc
                              6.2.4.1. Company overview
                              6.2.4.2. Financial performance
                              6.2.4.3. Product benchmarking
                              6.2.4.4. Strategic initiatives
                         6.2.5. NEURESCUE
                              6.2.5.1. Company overview
                              6.2.5.2. Financial performance
                              6.2.5.3. Product benchmarking
                              6.2.5.4. Strategic initiatives
                         6.2.6. Emergency Scientific, LLC
                              6.2.6.1. Company overview
                              6.2.6.2. Financial performance
                              6.2.6.3. Product benchmarking
                              6.2.6.4. Strategic initiatives
                         6.2.7. Qx Médical
                              6.2.7.1. Company overview
                              6.2.7.2. Financial performance
                              6.2.7.3. Product benchmarking
                              6.2.7.4. Strategic initiatives
                         6.2.8. Front Line Medical Technologies
                              6.2.8.1. Company overview
                              6.2.8.2. Financial performance
                              6.2.8.3. Product benchmarking
                              6.2.8.4. Strategic initiatives
                         6.2.9. Reboa Medical As
                              6.2.9.1. Company overview
                              6.2.9.2. Financial performance
                              6.2.9.3. Product benchmarking
                              6.2.9.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
Table 3 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 4 U.S. resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 5 Canada resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 6 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
Table 7 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 8 Germany resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 9 UK resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 10 France resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 11 Italy resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 12 Spain resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 13 Asia Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
Table 14 Aisa Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 15 China resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 16 Japan resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: market outlook
Fig. 9 Resuscitative endovascular balloon occlusion of the aorta (REBOA) competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market driver impact
Fig. 13 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market restraint impact
Fig. 14 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use movement analysis
Fig. 15 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use outlook and key takeaways
Fig. 16 Cardiac arrest market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Aortic occlusion market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Tactical combat casualty care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional movement analysis
Fig. 20 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional outlook and key takeaways
Fig. 21 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market share and leading players
Fig. 22 North America, by country
Fig. 23 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 U.S. key country dynamics
Fig. 25 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Canada key country dynamics
Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 UK key country dynamics
Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Germany key country dynamics
Fig. 32 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 France key country dynamics
Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Italy key country dynamics
Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Spain key country dynamics
Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 China key country dynamics
Fig. 41 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Japan key country dynamics
Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)